148 related articles for article (PubMed ID: 8029405)
1. Small hepatocellular carcinoma treated with percutaneous ethanol injection: unenhanced and gadolinium-enhanced MR imaging follow-up.
Sironi S; De Cobelli F; Livraghi T; Villa G; Zanello A; Taccagni G; DelMaschio A
Radiology; 1994 Aug; 192(2):407-12. PubMed ID: 8029405
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
[TBL] [Abstract][Full Text] [Related]
3. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
4. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up.
Sironi S; Livraghi T; Meloni F; De Cobelli F; Ferrero C; Del Maschio A
AJR Am J Roentgenol; 1999 Nov; 173(5):1225-9. PubMed ID: 10541093
[TBL] [Abstract][Full Text] [Related]
5. Plain and gadolinium-DTPA-enhanced MR imaging of hepatocellular carcinoma treated with transarterial chemoembolization.
Castrucci M; Sironi S; De Cobelli F; Salvioni M; Del Maschio A
Abdom Imaging; 1996; 21(6):488-94. PubMed ID: 8875869
[TBL] [Abstract][Full Text] [Related]
6. Small hepatocellular carcinoma: MR follow-up of treatment with percutaneous ethanol injection.
Sironi S; Livraghi T; Angeli E; Vanzulli A; Villa G; Colombo E; Taccagni G; DelMaschio A
Radiology; 1993 Apr; 187(1):119-23. PubMed ID: 8383864
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma of the oral cavity: MR findings and value of T1-versus T2-weighted fast spin-echo images.
Yasumoto M; Shibuya H; Takeda M; Korenaga T
AJR Am J Roentgenol; 1995 Apr; 164(4):981-7. PubMed ID: 7726062
[TBL] [Abstract][Full Text] [Related]
8. Liver tumors: comparison of MR imaging with Gd-EOB-DTPA and Gd-DTPA.
Vogl TJ; Kümmel S; Hammerstingl R; Schellenbeck M; Schumacher G; Balzer T; Schwarz W; Müller PK; Bechstein WO; Mack MG; Söllner O; Felix R
Radiology; 1996 Jul; 200(1):59-67. PubMed ID: 8657946
[TBL] [Abstract][Full Text] [Related]
9. Hepatic malignancies: usefulness of acquisition of multiple arterial and portal venous phase images at dynamic gadolinium-enhanced MR imaging.
Peterson MS; Baron RL; Murakami T
Radiology; 1996 Nov; 201(2):337-45. PubMed ID: 8888220
[TBL] [Abstract][Full Text] [Related]
10. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
11. Liver metastases: improved detection with dynamic gadolinium-enhanced MR imaging?
Hamm B; Mahfouz AE; Taupitz M; Mitchell DG; Nelson R; Halpern E; Speidel A; Wolf KJ; Saini S
Radiology; 1997 Mar; 202(3):677-82. PubMed ID: 9051015
[TBL] [Abstract][Full Text] [Related]
12. Treatment of hepatocellular carcinoma by chemoembolization: evaluation with 3DFT MR imaging.
Murakami T; Nakamura H; Tsuda K; Nakanishi K; Hori S; Tomoda K; Mitani T; Kozuka T; Monden M; Wakasa K
AJR Am J Roentgenol; 1993 Feb; 160(2):295-9. PubMed ID: 8380948
[TBL] [Abstract][Full Text] [Related]
13. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
Kim JE; Kim SH; Lee SJ; Rhim H
AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous ethanol injection therapy for hepatocellular carcinoma: validity of MR imaging in the evaluation of treatment effect.
Usui H; Itai Y
Radiat Med; 1995; 13(3):103-8. PubMed ID: 7569000
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
[TBL] [Abstract][Full Text] [Related]
16. MR imaging of peritoneal disease: comparison of contrast-enhanced fast multiplanar spoiled gradient-recalled and spin-echo imaging.
Low RN; Sigeti JS
AJR Am J Roentgenol; 1994 Nov; 163(5):1131-40. PubMed ID: 7976889
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced MR imaging of hepatic lesions treated with percutaneous ethanol ablation therapy.
Nagel HS; Bernardino ME
Radiology; 1993 Oct; 189(1):265-70. PubMed ID: 7690490
[TBL] [Abstract][Full Text] [Related]
18. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images.
Semelka RC; Brown ED; Ascher SM; Patt RH; Bagley AS; Li W; Edelman RR; Shoenut JP; Brown JJ
Radiology; 1994 Aug; 192(2):401-6. PubMed ID: 8029404
[TBL] [Abstract][Full Text] [Related]
19. Hypervascular liver lesions: differentiation of focal nodular hyperplasia from malignant tumors with dynamic gadolinium-enhanced MR imaging.
Mahfouz AE; Hamm B; Taupitz M; Wolf KJ
Radiology; 1993 Jan; 186(1):133-8. PubMed ID: 8416554
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic adenocarcinoma: assessment of vascular invasion with high-field MR imaging and a phased-array coil.
Sironi S; De Cobelli F; Zerbi A; Angeli E; Balzano G; Taccagni G; Di Carlo V; Del Maschio A
AJR Am J Roentgenol; 1996 Oct; 167(4):997-1001. PubMed ID: 8819400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
